Sign inJoin waitlistJoin the waitlist

Sai Yendamuri

Chief of Thoracic Surgery for Roswell Park · University at Buffalo School of Medicine

Credentials: · · · · ·

History

Thoracic Surgery for Roswell Park Division · University at Buffalo School of Medicine
Present
University at Buffalo School of Medicine
Present

Thoracic Surgery
MD Anderson Cancer Center
2005–2006
New York Presbyterian Hospital
1998–2005
Bachelor of Medicine, Bachelor of Surgery
1993–1997

Research

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Proceedings of the National Academy of Sciences of the United States of America · 2004 · 3,299 citations
Admission hyperglycemia as a prognostic indicator in trauma
The Journal of trauma · 2003 · First of 3 authors · 290 citations
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection
Cancer Research · 2010 · Last of 4 authors · 207 citations

Todd Demmy
59 papers
MH
Mark Hennon
37 papers · 3 as a fellow
Chukwumere Nwogu
36 papers
Elisabeth Dexter
21 papers
AP
Anthony Picone
15 papers
SD
Samjot Dhillon
15 papers
Grace Dy
10 papers
Sarbajit Mukherjee
10 papers · 2 as a fellow
Yeshwanth Vedire
10 papers · 9 as a resident
Caleb Hartman
8 papers · 2 as a resident
CL
Charles Leduc
8 papers
David Christiani
8 papers

Grants

Metformin for Chemoprevention of Lung Cancer in Obese Subjects at High Risk
National Cancer Institute · R01
Contact PI · $3.4M · Roswell Park Cancer Institute Corp
2021–2027
Post-Doctoral Research Training in Surgical Oncology
National Cancer Institute · T32
Contact PI · $223.7K · Roswell Park Cancer Institute Corp
2006–2022
MicroRNA Profiling to Predict Recurrence After Resection of Early Lung Cancer
National Cancer Institute · K23
Contact PI · $937.3K · Roswell Park Cancer Institute Corp
2011–2018

Clinical trials

Testing the SurVaxM Vaccine for Lung Cancer Prevention
Principal investigator · Not yet recruiting · Phase 2
National Cancer Institute (NCI)
2026–2029
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Principal investigator · Active not recruiting · Phase 2
Northwestern University
2022–2027
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Principal investigator · Terminated · Phase 1
Roswell Park Cancer Institute
2022–2025
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Principal investigator · Completed · Phase 1
Roswell Park Cancer Institute
2021–2025